Source: Eur Respir J, 49 (6) 1602098; 10.1183/13993003.02098-2016
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Benjamin M. Tang, Maryam Shojaei, Grant P. Parnell, Stephen Huang, Marek Nalos, Sally Teoh, Kate O'Connor, Stephen Schibeci, Amy L. Phu, Anand Kumar, John Ho, Adrienne F. A. Meyers, Yoav Keynan, Terry Ball, Amarnath Pisipati, Aseem Kumar, Elizabeth Moore, Damon Eisen, Kevin Lai, Mark Gillett, Robert Geffers, Hao Luo, Fahad Gul, Jens Schreiber, Sandra Riedel, David Booth, Anthony McLean, Klaus Schughart. A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection. Eur Respir J, 49 (6) 1602098; 10.1183/13993003.02098-2016

Member's Comments

No comment yet.

Related content which might interest you: The role of viral and bacterial infections in asthma severity Source: Annual Congress 2005 - PG3 - Asthma: natural history, risk factors and overall management Year: 2005 The immunology of virus infection in asthma Source: Eur Respir J 2001; 18: 1013-1025 Year: 2001 A novel immune regulatory function of neutrophils in rhinovirus infections Source: Lung Science Conference 2015 Year: 2015 RT-PCR microarray detection of viral respiratory pathogens demonstrates the major role of human metapneumovirus and human rhinovirus in acute exacerbations of COPD in France Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010 LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations? Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 Pathomechanisms mediating bacterial co-infection following respiratory viral disease Source: Lung Science Conference 2015 Year: 2015 Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients Source: Eur Respir J 2002; 20: 28S-39S Year: 2002 Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1 Source: Eur Respir J 2011; 38: 739-742 Year: 2011 Viruses in asthma and COPD: mechanisms and defence Source: Annual Congress 2005 - Microorganisms: good, bad or ugly in allergic respiratory disease Year: 2005 EBV and CMV as possible pathogens in patients presenting with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 MERS-COV, SARS and related respiratory pathogens Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage Year: 2017 Cationic host defence peptides as a novel treatment for respiratory viral infections Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung Year: 2018 Clinical and virusological effectiveness study of ultralow doses of antibodies to interferon-gamma in treatment of acute respiratory viral infections and influenza in children Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009 The role bacterial and viral infection in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Prevalance of chlamydia, mycoplasma, legionella and influenza A antibodies in acute exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 484s Year: 2001 The innate defence peptide BPIFA1/SPLUNC1 restricts respiratory viral infections Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma Year: 2019 Diffusion ability of the lungs in the assessment of respiratory function in patients who have undergone the new coronavirus infection (COVID-19) Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 LSC Abstract – A novel immune regulatory function of neutrophils in rhinovirus infections Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015